Form 4: Sagimet Biosciences Director Sells Shares
Insider Transaction (Form 4)
George Kemble, a Director of Sagimet Biosciences Inc., sold 18,844 shares of common stock on July 20, 2026 for $7.46 per share.
Summary
- Open-market sale: disposed of 18,844 Series A Common Stock at $7.46 ($140,529) on July 20, 2026; holds 62,161 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $140,529 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
George Kemble — Director
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-20 | Open-market sale | Series A Common Stock | 18,844 | $7 | $140.5K | 62,161 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-20 | Open-market sale (18,844 shares) |
Keywords
insider transaction, Form 4, SGMT, Sagimet Biosciences Inc., bearish, George Kemble
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.